NEUROG3
Basic information
Region (hg38): 10:69571698-69573422
Links
Phenotypes
GenCC
Source:
- permanent neonatal diabetes mellitus (Strong), mode of inheritance: AR
- congenital malabsorptive diarrhea 4 (Strong), mode of inheritance: AR
- congenital malabsorptive diarrhea 4 (Strong), mode of inheritance: AR
- congenital malabsorptive diarrhea 4 (Supportive), mode of inheritance: AR
- congenital malabsorptive diarrhea 4 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Diarrhea 4, malabsorptive, congenital | AR | Gastrointestinal | Individuals may present in infancy with severe hyperchloremic metabolic acidosis due to vomiting and diarrhea, and may require parenteral nutrition and limited enteral feeding (with oral vitamins and electrolyte supplementation); Surveillance may allow early recognition and treatment of diabetes mellitus (including with insulin); One reported individual required liver/intestinal transplant | Endocrine; Gastrointestinal | 16855267; 21490072 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
- Congenital malabsorptive diarrhea 4 (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NEUROG3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 34 | 36 | ||||
missense | 67 | 74 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 4 | 3 | 73 | 34 | 8 |
Variants in NEUROG3
This is a list of pathogenic ClinVar variants found in the NEUROG3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-69572414-G-A | Likely benign (Mar 19, 2022) | |||
10-69572415-A-G | Uncertain significance (Jul 17, 2023) | |||
10-69572420-C-G | Likely benign (Nov 13, 2023) | |||
10-69572420-C-CAG | Uncertain significance (Jul 21, 2023) | |||
10-69572422-G-A | Likely benign (Aug 19, 2022) | |||
10-69572435-C-G | Uncertain significance (May 04, 2021) | |||
10-69572439-C-A | Uncertain significance (Feb 04, 2022) | |||
10-69572448-A-G | not specified • Congenital malabsorptive diarrhea 4 | Benign (Feb 01, 2024) | ||
10-69572450-G-T | Likely benign (Dec 12, 2022) | |||
10-69572459-C-T | Congenital malabsorptive diarrhea 4 | Likely benign (Nov 25, 2023) | ||
10-69572462-C-A | Likely benign (Dec 04, 2023) | |||
10-69572463-A-C | Uncertain significance (Dec 30, 2023) | |||
10-69572467-C-T | Inborn genetic diseases | Uncertain significance (Jan 30, 2024) | ||
10-69572472-C-T | Uncertain significance (Aug 01, 2022) | |||
10-69572473-G-A | Uncertain significance (Aug 16, 2022) | |||
10-69572473-G-T | Likely benign (Jul 21, 2023) | |||
10-69572485-A-T | Inborn genetic diseases | Uncertain significance (Mar 23, 2023) | ||
10-69572487-G-A | Uncertain significance (Aug 26, 2021) | |||
10-69572488-C-T | Uncertain significance (Feb 03, 2022) | |||
10-69572491-C-A | Uncertain significance (Aug 19, 2022) | |||
10-69572492-G-A | Benign (Nov 25, 2023) | |||
10-69572504-G-A | Likely benign (Oct 13, 2023) | |||
10-69572505-C-T | Uncertain significance (Apr 12, 2022) | |||
10-69572506-C-T | Uncertain significance (Mar 19, 2022) | |||
10-69572509-C-A | Uncertain significance (May 25, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NEUROG3 | protein_coding | protein_coding | ENST00000242462 | 1 | 1541 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000596 | 0.151 | 125681 | 0 | 32 | 125713 | 0.000127 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.517 | 143 | 127 | 1.13 | 0.00000595 | 1325 |
Missense in Polyphen | 39 | 37.962 | 1.0273 | 421 | ||
Synonymous | -0.491 | 64 | 59.2 | 1.08 | 0.00000287 | 495 |
Loss of Function | -0.686 | 7 | 5.30 | 1.32 | 2.46e-7 | 49 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000413 | 0.000410 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.0000447 | 0.0000440 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.000335 | 0.000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a transcriptional regulator. Together with NKX2- 2, initiates transcriptional activation of NEUROD1. Involved in neurogenesis. Also required for the specification of a common precursor of the 4 pancreatic endocrine cell types (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Diarrhea 4, malabsorptive, congenital (DIAR4) [MIM:610370]: A disease characterized by severe, life-threatening watery diarrhea associated with generalized malabsorption and a paucity of enteroendocrine cells. {ECO:0000269|PubMed:16855267}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Maturity onset diabetes of the young - Homo sapiens (human);Notch-mediated HES/HEY network
(Consensus)
Recessive Scores
- pRec
- 0.200
Intolerance Scores
- loftool
- 0.381
- rvis_EVS
- 0.24
- rvis_percentile_EVS
- 68.98
Haploinsufficiency Scores
- pHI
- 0.0709
- hipred
- N
- hipred_score
- 0.290
- ghis
- 0.392
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.283
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Neurog3
- Phenotype
- renal/urinary system phenotype; digestive/alimentary phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;nervous system development;central nervous system development;peripheral nervous system development;spinal cord development;epithelial cell differentiation;forebrain development;hindbrain development;endocrine pancreas development;positive regulation of neuron differentiation;positive regulation of transcription by RNA polymerase II;regulation of dendrite morphogenesis;positive regulation of DNA-binding transcription factor activity;transdifferentiation
- Cellular component
- nucleus;cytoplasm
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;transcription coactivator activity;protein binding;chromatin DNA binding;protein dimerization activity